The second set address the changing emphasis of GPCR-directed drug discovery; this is shifting from a traditional focus on biogenic monoamine receptors, which have natural ligands that are readily ...

This increase in monoamine neurotransmitter concentrations results in increased binding at postsynaptic receptors. Monoamine oxidase is an enzyme found in both neurons and liver cells. This enzyme ...